Literature DB >> 21921568

Intra- and interobserver variability of intrapartum cardiotocography: a multicenter study comparing the FIGO classification with computer analysis software.

S Schiermeier1, G Westhof, A Leven, H Hatzmann, J Reinhard.   

Abstract

OBJECTIVE: To evaluate and compare the computer analyzing software system with subjective interpretation using the FIGO classification of intrapartum cardiotocograms.
METHODS: Twenty-four obstetricians and 19 midwives from 3 hospitals [19 junior (≤3 years) and 24 senior (>3 years) experience] participated in this study. Forty-three doctors and midwives interpreted intrapartum cardiotocographic (CTG) readings from 12 parturients without knowing the clinical outcome. Two CTG readings were repeated for evaluation of the intraobserver variability. Inter- and intraobserver agreement in CTG interpretation using the FIGO score and the computer analyzing software was assessed via proportions of agreement (Pa), with 95% confidence intervals. The level of inter- and intraobserver agreement was analyzed by calculating Pa values for CTG baseline, variability, accelerations and decelerations.
RESULTS: In total, for all parameters of the FIGO classification, Pa was very low. The highest 95% confidence level of Pa was found for the baseline parameter (0.49-1.01), and the lowest for the parameter acceleration. No significant difference was seen between obstetricians and midwives as well as between junior and senior experience. In assessments of normal cases, the Pa were significantly higher than in pathological readings.
CONCLUSION: Computer analyzing software can reduce the high inter- and intraobserver variability; however, further studies are needed to find out whether this can improve fetal outcome and reduce the number of Cesarean sections.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2011        PMID: 21921568     DOI: 10.1159/000327133

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  8 in total

1.  Non-invasive Foetal ECG - a Comparable Alternative to the Doppler CTG?

Authors:  J Reinhard; F Louwen
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-03       Impact factor: 2.915

2.  Nonreassuring fetal heart rate decreases heart rate variability in newborn infants.

Authors:  Tzong-Chyi Sheen; Ming-Huei Lu; Mei-Yu Lee; Su-Ru Chen
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-05       Impact factor: 1.468

3.  Comparison of a novel computerized analysis program and visual interpretation of cardiotocography.

Authors:  Chen-Yu Chen; Chun Yu; Chia-Chen Chang; Chii-Wann Lin
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

4.  Fetal heart rate monitoring of short term variation (STV): a methodological observational study.

Authors:  Stina Wretler; Malin Holzmann; Sophie Graner; Pelle Lindqvist; Susanne Falck; Lennart Nordström
Journal:  BMC Pregnancy Childbirth       Date:  2016-03-16       Impact factor: 3.007

5.  A Comprehensive Evaluation of the Predictive Abilities of Fetal Electrocardiogram-Derived Parameters during Labor in Newborn Acidemia: Our Institutional Experience.

Authors:  Ning Tian; Weiyuan Zhang
Journal:  Biomed Res Int       Date:  2018-05-17       Impact factor: 3.411

6.  Fetal Heart Rate Monitoring Implemented by Dynamic Adaptation of Transmission Power of a Flexible Ultrasound Transducer Array.

Authors:  Paul Hamelmann; Massimo Mischi; Alexander F Kolen; Judith O E H van Laar; Rik Vullings; Jan W M Bergmans
Journal:  Sensors (Basel)       Date:  2019-03-08       Impact factor: 3.576

7.  Cardiotocography in Obstetrics: New Solutions for "Routine" Technology.

Authors:  Vladimir Kodkin
Journal:  Sensors (Basel)       Date:  2022-07-08       Impact factor: 3.847

8.  Intrapartal cardiotocographic patterns and hypoxia-related perinatal outcomes in pregnancies complicated by gestational diabetes mellitus.

Authors:  Mikko Tarvonen; Petteri Hovi; Susanna Sainio; Piia Vuorela; Sture Andersson; Kari Teramo
Journal:  Acta Diabetol       Date:  2021-06-21       Impact factor: 4.280

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.